TDG Form 4: Director receives 518 stock options, 2035 expiry
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
TransDigm Group (TDG): Director Peter Palmer reported an equity grant on Form 4. He acquired stock options covering 518 shares on Nov 4, 2025 with an exercise price of $1,291.97 per share and an expiration date of Nov 4, 2035.
The options vest at 20% per year over five years, beginning Sept 30, 2026, and are subject to the achievement of annual operating performance targets each year. Following the transaction, 518 derivative securities were beneficially owned on a direct basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Palmer Peter
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 518 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 518 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did TDG disclose in this Form 4?
A director reported acquiring 518 stock options on Nov 4, 2025.
What is the exercise price of the options reported by TDG's director?
The options have an exercise price of $1,291.97 per share.
When do the TDG options vest and what are the conditions?
They vest 20% per year over five years starting Sept 30, 2026, subject to annual operating performance targets.
When do the reported TDG options expire?
The options expire on Nov 4, 2035.
How many derivative securities are beneficially owned after this transaction?
518 derivative securities were beneficially owned after the transaction.
What is the reporting person's relationship to TDG?
The reporting person is a Director of TDG.
What is the ownership form of the reported options?
The options are held on a direct ownership basis.